HIGHLIGHTS
- who: Ortiz and collaborators from the Department of Pharmacy, State Key Laboratory of Biotherapy and Center, National Clinical Research Center for Geriatrics, China Hospital, Sichuan University, Chengdu, China have published the paper: Nanomedicines for Overcoming Resistance, in the Journal: Pharmaceutics 2022, 14, 1606. of 29/07/2022
- what: Among the primary goals of nanomedicines is to ensure therapeutic agents to be delivered into tumor cells at sufficient local concentrations with minimal loss of their activity in the bloodstream.
- how: They studied the pharmacokinetics of DOX-PLGA/CPT/PD and the results showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.